Managing neovascular age-related macular degeneration: a step into the light.
Guymer
Robyn H
RH
D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D020256:Choroidal Neovascularization / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D014943:Global Health; D006801:Humans; D015994:Incidence; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D008875:Middle Aged; D010778:Photochemotherapy / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D000069579:Ranibizumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab